Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT04929483 · COMPLETED
Trial details
- NCT number
- NCT04929483
- Sponsor
- 89bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-04
- Primary completion
- 2023-02-14
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.